𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome

✍ Scribed by Dr. Peter C. Dau; Eric H. Denys

Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
636 KB
Volume
11
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Electrophysiological and clinical correl
Electrophysiological and clinical correlations in the Lambert-Eaton myasthenic syndrome
✍ Shin J. Oh; Doo E. Kim; Reha Kuruoglu; Jordan Brooks; Gwendolyn Claussen πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 273 KB πŸ‘ 2 views

has not been any report which studied systematically the relationship between the repetitive nerve stimulation (RNS) test and severity of Lambert-Eaton myasthenic syndrome (LEMS) . We report such a study here. ## Methods This study was based on 57 RNS tests on the abductor digiti quinti (ADO musc

Immunosuppressive drug therapy with plas
Immunosuppressive drug therapy with plasmapheresis in chronic progressive multiple sclerosis: A controlled study
✍ B. O. Khatri; G. J. Harrington; D. Schmoll; M. P. McQuillen πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 185 KB

Although t h e e x a c t p a t h o g e n e s i s of m u l t i p l e s c l e r o s i s (MS) remains unknown, much r e c e n t d a t a s u g g e s t s t h a t M S may be an autoimmune d i s o r d e r . The i n c r e a s e d p r o d u c t i o n of immunoglobulin (IgG) w i t h i n t h e blood b r a i n

Low-dose guanidine and pyridostigmine: r
Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome
✍ Shin J. Oh; Dae S. Kim; Thomas C. Head; Gwen C. Claussen πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 1 views

Guanidine hydrochloride is known to be highly effective in the symptomatic treatment of the Lambert-Eaton myasthenic syndrome (LEMS). However, because of its potentially dangerous side reactions of hematologic abnormalities and renal insufficiency, 3,4-diaminopyridine, which is not readily available